Peptonic has completed the acquisition of a majority of the shares in Lune Group Oy
Stockholm, June 3[rd], 2020 - On 14 May 2020, Peptonic Medical AB (publ) (“Peptonic” or the “Company”) announced that the Company had entered into an agreement to acquire a majority of the shares in Lune Group Oy (“Lune”). All conditions for the acquisition pursuant to the agreement have been fulfilled and Peptonic has today completed the acquisition of 60 existing shares in Lune. In connection with the completion, the board has resolved on an issue of 12,228,133 new shares against payment in kind to the current shareholders of Lune as payment for the existing shares in Lune. The board has